Christie Edward M III's Form 4 filing
Encompass Health Corp (EHC) · filed Jul 16, 2026
- Accession no.
- 0000785161-26-000178
- Filed
- Jul 16, 2026, 4:21 PM ET
- Trade date
- Jul 15-16, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christie Edward M IIICIK 0001428519 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Encompass Health Common Stock | AGrant or awardAcquired | +11 | $0.00 | $0 | 9,097 | Direct | |
| Jul 16, 2026 | Encompass Health Common Stock | AGrant or awardAcquired | +248 | $112.43F3 | +$27,882.64 | 9,345 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.40 to $112.43, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Referenced by the price of 1 transaction in Table I.